Logo image of XMTR

XOMETRY INC-A (XMTR) Stock Fundamental Analysis

NASDAQ:XMTR - Nasdaq - US98423F1093 - Common Stock - Currency: USD

47.68  +0.5 (+1.06%)

After market: 48.63 +0.95 (+1.99%)

Fundamental Rating

4

XMTR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 50 industry peers in the Trading Companies & Distributors industry. The financial health of XMTR is average, but there are quite some concerns on its profitability. XMTR shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

XMTR had positive earnings in the past year.
In the past year XMTR had a positive cash flow from operations.
In the past 5 years XMTR always reported negative net income.
In the past 5 years XMTR always reported negative operating cash flow.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -8.97%, XMTR is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
XMTR has a worse Return On Equity (-22.78%) than 88.00% of its industry peers.
Industry RankSector Rank
ROA -8.97%
ROE -22.78%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

XMTR's Gross Margin of 39.15% is fine compared to the rest of the industry. XMTR outperforms 70.00% of its industry peers.
XMTR's Gross Margin has improved in the last couple of years.
XMTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
XMTR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for XMTR has been increased compared to 5 years ago.
The debt/assets ratio for XMTR is higher compared to a year ago.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

XMTR has an Altman-Z score of 3.68. This indicates that XMTR is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.68, XMTR is in line with its industry, outperforming 60.00% of the companies in the same industry.
A Debt/Equity ratio of 1.21 is on the high side and indicates that XMTR has dependencies on debt financing.
XMTR's Debt to Equity ratio of 1.21 is on the low side compared to the rest of the industry. XMTR is outperformed by 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 3.68
ROIC/WACCN/A
WACC9.63%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 3.91 indicates that XMTR has no problem at all paying its short term obligations.
XMTR has a better Current ratio (3.91) than 88.00% of its industry peers.
XMTR has a Quick Ratio of 3.85. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.85, XMTR belongs to the best of the industry, outperforming 98.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 3.85
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 200.00% over the past year.
The Revenue has grown by 20.19% in the past year. This is a very strong growth!
Measured over the past years, XMTR shows a very strong growth in Revenue. The Revenue has been growing by 46.73% on average per year.
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1000%
Revenue 1Y (TTM)20.19%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%22.59%

3.2 Future

The Earnings Per Share is expected to grow by 189.04% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 17.49% on average over the next years. This is quite good.
EPS Next Y683.44%
EPS Next 2Y301.43%
EPS Next 3Y189.04%
EPS Next 5YN/A
Revenue Next Year19.58%
Revenue Next 2Y18.32%
Revenue Next 3Y17.67%
Revenue Next 5Y17.49%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

XMTR is valuated quite expensively with a Price/Earnings ratio of 250.95.
Compared to the rest of the industry, the Price/Earnings ratio of XMTR indicates a slightly more expensive valuation: XMTR is more expensive than 74.00% of the companies listed in the same industry.
XMTR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.87.
XMTR is valuated quite expensively with a Price/Forward Earnings ratio of 67.56.
74.00% of the companies in the same industry are cheaper than XMTR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 35.34. XMTR is valued rather expensively when compared to this.
Industry RankSector Rank
PE 250.95
Fwd PE 67.56
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

XMTR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XMTR's earnings are expected to grow with 189.04% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y301.43%
EPS Next 3Y189.04%

More info and screens

0

5. Dividend

5.1 Amount

XMTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOMETRY INC-A

NASDAQ:XMTR (8/15/2025, 7:01:22 PM)

After market: 48.63 +0.95 (+1.99%)

47.68

+0.5 (+1.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners95.07%
Inst Owner Change3.56%
Ins Owners5.8%
Ins Owner Change12.04%
Market Cap2.42B
Analysts80
Price Target35.83 (-24.85%)
Short Float %13.18%
Short Ratio8.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)319.09%
Min EPS beat(2)96.56%
Max EPS beat(2)541.62%
EPS beat(4)4
Avg EPS beat(4)230.87%
Min EPS beat(4)96.56%
Max EPS beat(4)541.62%
EPS beat(8)8
Avg EPS beat(8)136.96%
EPS beat(12)11
Avg EPS beat(12)97.33%
EPS beat(16)14
Avg EPS beat(16)77.75%
Revenue beat(2)1
Avg Revenue beat(2)0.86%
Min Revenue beat(2)-0.07%
Max Revenue beat(2)1.79%
Revenue beat(4)2
Avg Revenue beat(4)0.52%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.79%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.8%
Revenue beat(16)9
Avg Revenue beat(16)-0.15%
PT rev (1m)1.81%
PT rev (3m)8.26%
EPS NQ rev (1m)1.45%
EPS NQ rev (3m)-9.2%
EPS NY rev (1m)0%
EPS NY rev (3m)1.34%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-0.05%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 250.95
Fwd PE 67.56
P/S 4
P/FCF N/A
P/OCF 1812.77
P/B 8.94
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.19
EY0.4%
EPS(NY)0.71
Fwd EY1.48%
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)0.03
OCFY0.06%
SpS11.91
BVpS5.34
TBVpS-0.47
PEG (NY)0.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.97%
ROE -22.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.15%
FCFM N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.13%
Cap/Sales 3.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 3.85
Altman-Z 3.68
F-Score5
WACC9.63%
ROIC/WACCN/A
Cap/Depr(3y)161.93%
Cap/Depr(5y)158.79%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1000%
EPS Next Y683.44%
EPS Next 2Y301.43%
EPS Next 3Y189.04%
EPS Next 5YN/A
Revenue 1Y (TTM)20.19%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%22.59%
Revenue Next Year19.58%
Revenue Next 2Y18.32%
Revenue Next 3Y17.67%
Revenue Next 5Y17.49%
EBIT growth 1Y19.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.73%
EBIT Next 3Y63.14%
EBIT Next 5Y47.19%
FCF growth 1Y69.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y102.61%
OCF growth 3YN/A
OCF growth 5YN/A